1 year return (CAGR)
67.36%
Enanta Pharmaceuticals Inc Exchange (NASDAQ, USD)
ENTA
12.00
+0.05 (+0.42%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-2.23%
5 year return (CAGR)
-27.05%
10 year return (CAGR)
-6.79%
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
349.50M
Price/Sales
5.36
Ent value
511.89M
Price/Book
3.46
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
16.17%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 11.94 |
| Daily high | 12.02 |
| Daily low | 11.67 |
| Daily Volume | 206K |
| All-time high | 126.37 |
| 1y analyst estimate | 19.80 |
| Beta | 0.93 |
| EPS (TTM) | -2.17 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 11 May 2026 |
Downside potential
Loading...
Downside potential data
| ENTA | S&P500 | |
| Current price drop from All-time high | -90.50% | -1.38% |
| Highest price drop | -96.63% | -56.47% |
| Date of highest drop | 10 Apr 2025 | 9 Mar 2009 |
| Avg drop from high | -50.11% | -10.68% |
| Avg time to new high | 44 days | 12 days |
| Max time to new high | 2065 days | 1805 days |
News
